Related Experiment Video
Updated: Jun 25, 2025
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
377
Epidemiological trends in psoriatic arthritis: a comprehensive population-based study
Amir Haddad1,2, Perach Chen Elkayam3, Nili Stein3
1Rheumatology Unit, Carmel Medical Center, 7 Michal Street, Haifa, Israel. Amirha3@clalit.org.il.
Arthritis Research & Therapy
|May 27, 2024
Summary
Psoriatic arthritis (PsA) prevalence has tripled since 2006, indicating a significant rise in this chronic condition. This trend highlights increasing healthcare needs and economic burdens associated with PsA management.
Area of Science:
- Epidemiology
- Rheumatology
- Public Health
Background:
- Psoriatic arthritis (PsA) is a chronic inflammatory disease linked to psoriasis.
- Understanding PsA epidemiology is crucial for assessing global burden and risk factors.
- This study focuses on PsA trends in Israel from 2016-2022.
Purpose of the Study:
- To estimate temporal trends, prevalence, and incidence of PsA in Israel.
- To analyze demographic variations (age, gender, ethnicity) in PsA.
- To identify sociodemographic factors associated with PsA.
Main Methods:
- Utilized Clalit Health Services database covering over half of Israel's population.
- Employed algorithm-based definitions for PsA and psoriasis.
- Analyzed demographic data and calculated standardized rates; logistic regression used.
Main Results:
- PsA prevalence was 0.221% and incidence 13.54 per 100,000 in 2022.
- Prevalence has tripled since 2006, showing an upward trend.
- Higher prevalence observed in females, Jewish individuals, higher SES, and those with obesity.
Conclusions:
- The study reveals a significant increase in PsA prevalence in Israel.
- This rise indicates growing healthcare demands and economic impact.
- Further research is needed to understand the drivers behind these increasing PsA trends.
